RecruitingNot ApplicableNCT05741112

The Long COVID-19 Wearable Device Study

Sponsor

Scripps Translational Science Institute

Enrollment

100,500 participants

Start Date

Nov 16, 2023

Study Type

INTERVENTIONAL

Conditions

Postural Orthostatic tachycardia Syndrome Myalgic Encephalomyelitis Chronic Fatigue Syndrome Dysautonomia Long COVID Long Covid19

Summary

To further characterize Long COVID-19 by collecting data from individuals who already own wearable devices or are provided with a wearable device along with basic and enhanced educational materials to determine if both can improve Long COVID-19 symptom management and post-exertional malaise.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Wearable device for people with chronic fatigue syndrome, dysautonomia, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEWearable device

The treatment group will receive their wearable device and the enhanced education at the start of the study. Their outcomes will be compared with the control group who will receive at 3 months.